Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of IMDX will decline by -8.43% over the next 2 Weeks and hit $3.43 by Wednesday, May 6, 2026. In that time frame, IMDX's share price is expected to range between $3.03 and $3.84.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 6, 2026 | 3.03 | 3.43 | 3.84 |
| May 5, 2026 | 3.02 | 3.44 | 3.84 |
| May 4, 2026 | 2.91 | 3.32 | 3.75 |
| May 1, 2026 | 3.16 | 3.60 | 4.02 |
| Apr 30, 2026 | 3.02 | 3.46 | 3.85 |
| Apr 29, 2026 | 3.12 | 3.55 | 3.97 |
| Apr 28, 2026 | 3.14 | 3.56 | 3.97 |
| Apr 27, 2026 | 3.01 | 3.43 | 3.83 |
| Apr 24, 2026 | 3.33 | 3.71 | 4.12 |
| Apr 23, 2026 | 3.16 | 3.57 | 3.98 |
IMDX shares fell -6.13% in Thursday, April 23, 2026's trading session, dropping from a previous close of $3.75 to move at $3.52. The stock demonstrated notable intraday movement (see IMDX's key stats for a full breakdown), fluctuating between $3.32 and $3.70, a +11.30% trading range. While recent weeks have seen some volatility, IMDX has managed to secure a +16.56% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 543.43K shares changing hands, 78.61K more than the previous session. This amounted to $1.91M in total market activity.
Will IMDX Continue Its Upward Trend?
According to analyst ratings and projections for IMDX, Insight Molecular Diagnostics Inc. shares are anticipated to increase by +8.25%, potentially reaching $3.84 per share by May 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for IMDX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the IMDX stock forecast, now is a good time to buy IMDX stock because its current trading price is +2.51% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on IMDX covering social and institutional perspectives.
IMDX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into IMDX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.76% to 46.85%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.65%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.29%, maintains a neutral outlook for the long term. Insights into IMDX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Insight Molecular Diagnostics Short-Term Forecasts
IMDX Forecast For Next 5 Days
Our algorithm anticipates Insight Molecular Diagnostics (IMDX) stock could hit $3.10 by Apr 30, 2026. This represents a -12.02% fall from today's price, following a -13.50% change over the past five days.
IMDX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Insight Molecular Diagnostics Inc. (IMDX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.75, which would mean a -21.88% decrease from the current price of $3.52. Projections for this period range from a high of $4.20 to a low of $1.47.
IMDX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Insight Molecular Diagnostics's price over the next three months point to a rise. IMDX stock is expected to peak at $45.53 on Jun 24, 2026 after potentially dipping to $13.71 on Apr 23, 2026. On average, IMDX is likely to trade around $30.93 in the coming 90 days.
Insight Molecular Diagnostics Stock Forecast 2025
Based on our predictive models, Insight Molecular Diagnostics (IMDX) is expected to trade between $6.42 and $45.53 throughout 2026. This would result in an average price of $26.78, potentially offering investors a +660.80% return from current levels.
Insight Molecular Diagnostics Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Insight Molecular Diagnostics Inc. (IMDX) is positioned to show a strong performance in April 2026. The price is predicted to move between $13.71 and $24.32, settling at an average of $19.48. This could translate to a +453.41% gain.
May 2026
Based on current market signals, Insight Molecular Diagnostics Inc. is projected to trend may 2026. We forecast a trading range from $25.79 to $40.21, with a likely average price of $34.03. Investors could expect a potential return of +866.76%.
June 2026
Our predictive algorithms indicate Insight Molecular Diagnostics Inc. stock may see a shift in June 2026. The expected range spans $23.17–$45.53, with an average target of $34.17. This represents a positive outlook and a possible gain of +870.74%.
July 2026
Analyzing established trends, Insight Molecular Diagnostics Inc. looks set to move in July 2026. Projections place the stock between $19.09 and $40.85, averaging around $27.65. This suggests a +685.51% gain from current levels.
August 2026
Market indicators suggest Insight Molecular Diagnostics Inc. could experience notable changes during August 2026. Prices could fluctuate within $12.73 to $30.57, with a midpoint forecast of $19.43. The stock might deliver a +451.99% gain.
September 2026
Forecasting for September 2026, models estimate that Insight Molecular Diagnostics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.22 and $31.46, averaging $22.99. This signals a positive trajectory with potential returns around +553.12%.
October 2026
According to our latest forecast models, Insight Molecular Diagnostics Inc. (IMDX) is positioned to show a strong performance in October 2026. The price is predicted to move between $17.48 and $38.76, settling at an average of $31.86. This could translate to a +805.11% gain.
November 2026
Based on current market signals, Insight Molecular Diagnostics Inc. is projected to trend november 2026. We forecast a trading range from $23.92 to $34.86, with a likely average price of $29.57. Investors could expect a potential return of +740.06%.
December 2026
Our predictive algorithms indicate Insight Molecular Diagnostics Inc. stock may see a shift in December 2026. The expected range spans $6.42–$29.38, with an average target of $17.03. This represents a positive outlook and a possible gain of +383.81%.
January 2027
Analyzing established trends, Insight Molecular Diagnostics Inc. looks set to move in January 2027. Projections place the stock between $16.80 and $29.56, averaging around $21.68. This suggests a +515.91% gain from current levels.
February 2027
Market indicators suggest Insight Molecular Diagnostics Inc. could experience notable changes during February 2027. Prices could fluctuate within $13.90 to $32.95, with a midpoint forecast of $22.99. The stock might deliver a +553.12% gain.
March 2027
Forecasting for March 2027, models estimate that Insight Molecular Diagnostics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $4.02 and $27.65, averaging $19.35. This signals a positive trajectory with potential returns around +449.72%.
April 2027
According to our latest forecast models, Insight Molecular Diagnostics Inc. (IMDX) is positioned to show a strong performance in April 2027. The price is predicted to move between $1.31 and $19.63, settling at an average of $8.53. This could translate to a +142.33% gain.
IMDX's history of dividends and stock splits also plays a role in long-term investor confidence.